News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Oncotarget | Kinase Activity in Renal Cell Carcinoma, Benign Renal Tissue and in Response to Tyrosine Kinase Inhibitors

Oncotarget

August 17, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on August 4, 2022, entitled, “Kinase activity profiling in renal cell carcinoma, benign renal tissue and in response to four different tyrosine kinase inhibitors.” continue reading »

Aging | New Research: Volume 14, Issue 15

Aging

August 15, 2022
PRESS RELEASE: Aging published a new issue of the latest research on aging in Volume 14, Issue 15. continue reading »

Oncotarget | Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

News

August 11, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on August 3, 2022, entitled, “Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma.” continue reading »

Aging | Common Electrocardiogram Measures Are Not Associated With Telomere Length

Aging

August 10, 2022
PRESS RELEASE: A new research paper was published in Aging’s Volume 14, Issue 14, entitled, “Common electrocardiogram measures are not associated with telomere length.” continue reading »

Oncotarget | A Novel Mechanism of Regulation of the Oncogenic Transcription Factor GLI3 by Toll-like Receptor Signaling

News

August 9, 2022
PRESS RELEASE: A new research paper was published in Oncotarget on August 3, 2022, entitled, “A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling.” continue reading »